BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26469831)

  • 1. Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma.
    Ormanns S; Altendorf-Hofmann A; Jackstadt R; Horst D; Assmann G; Zhao Y; Bruns C; Kirchner T; Knösel T
    Br J Cancer; 2015 Nov; 113(10):1460-6. PubMed ID: 26469831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of desmoglein 2 and desmoglein 3 in esophageal squamous cell carcinoma.
    Fang WK; Gu W; Liao LD; Chen B; Wu ZY; Wu JY; Shen J; Xu LY; Li EM
    Asian Pac J Cancer Prev; 2014; 15(2):871-6. PubMed ID: 24568510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer.
    Ramani VC; Hennings L; Haun RS
    BMC Cancer; 2008 Dec; 8():373. PubMed ID: 19091121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of desmogleins 1-3 and their clinical impacts on human lung cancer.
    Saaber F; Chen Y; Cui T; Yang L; Mireskandari M; Petersen I
    Pathol Res Pract; 2015 Mar; 211(3):208-13. PubMed ID: 25468811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
    Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
    Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant expression of desmoglein 2 and 3 at the mRNA and protein levels in nodular and superficial basal cell carcinoma revealed by immunohistochemistry and fluorescent in situ hybridization.
    Pietkiewicz P; Gornowicz-Porowska J; Bowszyc-Dmochowska M; Jagielska J; Helak-Łapaj C; Kaczmarek E; Dmochowski M
    Clin Exp Dermatol; 2014 Jul; 39(5):628-35. PubMed ID: 24934917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma.
    Pozios I; Knösel T; Zhao Y; Assmann G; Pozios I; Müller MH; Bruns CJ; Kreis ME; Seeliger H
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1887-1897. PubMed ID: 30046904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
    Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer.
    Bronsert P; Kohler I; Timme S; Kiefer S; Werner M; Schilling O; Vashist Y; Makowiec F; Brabletz T; Hopt UT; Bausch D; Kulemann B; Keck T; Wellner UF
    Surgery; 2014 Jul; 156(1):97-108. PubMed ID: 24929761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma.
    Zhang SR; Li H; Wang WQ; Jin W; Xu JZ; Xu HX; Wu CT; Gao HL; Li S; Li TJ; Zhang WH; Xu SS; Ni QX; Yu XJ; Liu L
    Eur J Surg Oncol; 2019 May; 45(5):769-775. PubMed ID: 30416079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interspecies conservation and differential expression of mouse desmoglein gene family.
    Mahoney MG; Simpson A; Aho S; Uitto J; Pulkkinen L
    Exp Dermatol; 2002 Apr; 11(2):115-25. PubMed ID: 11994138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
    Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.
    Yang G; Wang Y; Xiao J; Zhao F; Qiu J; Liu Y; Chen G; Cao Z; You L; Zheng L; Zhang T; Zhao Y
    Cell Oncol (Dordr); 2021 Apr; 44(2):345-355. PubMed ID: 33125631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome.
    Dugnani E; Sordi V; Pellegrini S; Chimienti R; Marzinotto I; Pasquale V; Liberati D; Balzano G; Doglioni C; Reni M; Gandolfi A; Falconi M; Lampasona V; Piemonti L
    Pancreatology; 2018 Dec; 18(8):945-953. PubMed ID: 30293872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
    World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of correlation between intensities of desmoglein 2 and desmoglein 3 expression in basal cell carcinomas.
    Gornowicz-Porowska J; Bowszyc-Dmochowska M; Seraszek-Jaros A; Kaczmarek E; Dmochowski M
    Acta Dermatovenerol Croat; 2011; 19(3):150-5. PubMed ID: 21933638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.